Indeed, on 20 breast tumor samples which showed a FC of 23 between ER+ and ER− with Qiagen technology, we found a similar increase of miR-190b expression levels with Applied technology (FC of 26) (data not shown) and a strong positive correlation of miR-190b expression between the two techniques (Spearman’s coefficient correlation of 0.8977 significant at p < 0.0001). The gene discussed is ESR1; the disease is breast neoplasm.